Amalgamated Bank
- SEC CIK
- 0000919192
- Latest filing
- Jul 23, 2026
CERE holding history
Cerevel Therapeutics Holdings, Inc. in every 13F filed by Amalgamated Bank, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CERE overviewAll 13F holders of CEREFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −4,770−100.0% | Sold out | Holders |
| Q2 2024 | 4,770 | $195.0K | <0.1% | +2,385+100.0% | Added | Holders |
| Q1 2024 | 2,385 | $101.0K | <0.1% | −7,642−76.2% | Reduced | Holders |
| Q4 2023 | 10,027 | $425.0K | <0.1% | +809+8.8% | Added | Holders |
| Q3 2023 | 9,218 | $201.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 9,218 | $293.0K | <0.1% | +1,122+13.9% | Added | Holders |
| Q1 2023 | 8,096 | $197.0K | <0.1% | −1,462−15.3% | Reduced | Holders |
| Q4 2022 | 9,558 | $301.0K | <0.1% | +834+9.6% | Added | Holders |
| Q3 2022 | 8,724 | $247.0K | <0.1% | +138+1.6% | Added | Holders |
| Q2 2022 | 8,586 | $227.0K | <0.1% | +1,953+29.4% | Added | Holders |
| Q1 2022 | 6,633 | $232.0K | <0.1% | −497−7.0% | Reduced | Holders |
| Q4 2021 | 7,130 | $231.0K | <0.1% | +11+0.2% | Added | Holders |
| Q3 2021 | 7,119 | $210.0K | <0.1% | +7,119 | New | Holders |